RECURRENT ACUTE MYELOID LEUKEMIA
Clinical trials for RECURRENT ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First safety test of 'Off-the-Shelf' immune cells to fight tough leukemia
Disease control CompletedThis early-stage trial tested the safety of a new immune cell therapy for adults with acute myeloid leukemia that has come back or not responded to other treatments. Doctors gave patients natural killer (NK) cells from healthy donors to see if they could help the body fight the c…
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New drug combo aims to fight back when leukemia returns after transplant
Disease control CompletedThis study tested a two-part treatment for people whose acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) came back after a donor stem cell transplant. It combined a drug called guadecitabine, which may slow cancer growth, with infusions of the donor's white blood ce…
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo tested to fight Leukemia's return after transplant
Disease control CompletedThis early-stage study tested two immunotherapy drugs, nivolumab and ipilimumab, in patients with high-risk or returning acute myeloid leukemia or myelodysplastic syndrome who had already received a donor stem cell transplant. The main goals were to find safe doses and check for …
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Scientists test Triple-Threat attack on childhood cancer
Disease control CompletedThis study tested a new combination of three cancer drugs for children and young adults whose acute myeloid leukemia (AML) came back or did not respond to standard treatments. The main goal was to find the safest dose and understand the side effects. Researchers hoped this target…
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC